167 related articles for article (PubMed ID: 21726529)
1. Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR).
Polusani SR; Kar R; Riquelme MA; Masters BS; Panda SP
Biochem Biophys Res Commun; 2011 Aug; 411(3):490-5. PubMed ID: 21726529
[TBL] [Abstract][Full Text] [Related]
2. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
Marohnic CC; Panda SP; Martásek P; Masters BS
J Biol Chem; 2006 Nov; 281(47):35975-82. PubMed ID: 16998238
[TBL] [Abstract][Full Text] [Related]
3. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
[TBL] [Abstract][Full Text] [Related]
4. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase.
Shen AL; O'Leary KA; Kasper CB
J Biol Chem; 2002 Feb; 277(8):6536-41. PubMed ID: 11742006
[TBL] [Abstract][Full Text] [Related]
5. [Antley-Bixler syndrome or POR deficiency?].
Tomková M; Marohnic CC; Baxová A; Martásek P
Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
[TBL] [Abstract][Full Text] [Related]
6. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
Kranendonk M; Marohnic CC; Panda SP; Duarte MP; Oliveira JS; Masters BS; Rueff J
Arch Biochem Biophys; 2008 Jul; 475(2):93-9. PubMed ID: 18455494
[TBL] [Abstract][Full Text] [Related]
7. Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating antley-bixler syndrome: role of a redox enzyme in development.
Panda SP; Guntur AR; Polusani SR; Fajardo RJ; Gakunga PT; Roman LJ; Masters BS
PLoS One; 2013; 8(9):e75638. PubMed ID: 24086598
[TBL] [Abstract][Full Text] [Related]
8. Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
Moutinho D; Marohnic CC; Panda SP; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2012 Apr; 40(4):754-60. PubMed ID: 22252407
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
11. Chimeric enzymes of cytochrome P450 oxidoreductase and neuronal nitric-oxide synthase reductase domain reveal structural and functional differences.
Roman LJ; McLain J; Masters BS
J Biol Chem; 2003 Jul; 278(28):25700-7. PubMed ID: 12730215
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.
Xia C; Shen AL; Duangkaew P; Kotewong R; Rongnoparut P; Feix J; Kim JP
Biochemistry; 2019 May; 58(19):2408-2418. PubMed ID: 31009206
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for cell-specific regulation of the NADPH-cytochrome P450 oxidoreductase gene.
O'Leary KA; Kasper CB
Arch Biochem Biophys; 2000 Jul; 379(1):97-108. PubMed ID: 10864447
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes P450--a family of proteins and scientists-understanding their relationships.
Sue Masters B; Marohnic CC
Drug Metab Rev; 2006; 38(1-2):209-25. PubMed ID: 16684658
[TBL] [Abstract][Full Text] [Related]
15. Modeling of Anopheles minimus Mosquito NADPH-cytochrome P450 oxidoreductase (CYPOR) and mutagenesis analysis.
Sarapusit S; Lertkiatmongkol P; Duangkaew P; Rongnoparut P
Int J Mol Sci; 2013 Jan; 14(1):1788-801. PubMed ID: 23325047
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast and osteocyte-specific loss of Connexin43 results in delayed bone formation and healing during murine fracture healing.
Loiselle AE; Paul EM; Lewis GS; Donahue HJ
J Orthop Res; 2013 Jan; 31(1):147-54. PubMed ID: 22718243
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.
Xia C; Panda SP; Marohnic CC; Martásek P; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13486-91. PubMed ID: 21808038
[TBL] [Abstract][Full Text] [Related]
18. ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation.
McLachlan E; Plante I; Shao Q; Tong D; Kidder GM; Bernier SM; Laird DW
J Bone Miner Res; 2008 Jun; 23(6):928-38. PubMed ID: 18269311
[TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin-1 on osteoblastic differentiation is modified by the level of connexin43: comparative study on calvarial osteoblastic cells isolated from Cx43+/- and Cx43+/+ mice.
Geneau G; Lamiche C; Niger C; Strale PO; Clarhaut J; Defamie N; Debiais F; Mesnil M; Cronier L
Cell Tissue Res; 2010 Apr; 340(1):103-15. PubMed ID: 20195637
[TBL] [Abstract][Full Text] [Related]
20. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines.
Schmalix WA; Lang D; Schneider A; Bocker R; Greim H; Doehmer J
Drug Metab Dispos; 1996 Dec; 24(12):1314-9. PubMed ID: 8971136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
